Cytovation

Developerof peptide therapeutics to treat cutaneous warts caused by HPV

placeBergen, Vestland, Norway calendar_todayFounded 2001 groups10 employees language cytovation.com

Registered entities

Social engagement

Social engagement: 2K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Sandwater, Canica.

Investor typeCountShare
Venture capital267%
Private equity133%

Recent activity

18 May 2026
Partnership
BeOne Medicines
4 Feb 2026
Milestone
regulatory
Coming soon